| MeSH term | MeSH ID | Detail |
|---|---|---|
| Atrial Fibrillation | D001281 | 16 associated lipids |
| Pulmonary Disease, Chronic Obstructive | D029424 | 16 associated lipids |
| Vascular Diseases | D014652 | 16 associated lipids |
| Scleroderma, Systemic | D012595 | 16 associated lipids |
| Carotid Stenosis | D016893 | 15 associated lipids |
| Periodontal Diseases | D010510 | 15 associated lipids |
| Encephalitis | D004660 | 15 associated lipids |
| HIV Seropositivity | D006679 | 15 associated lipids |
| Synovitis | D013585 | 15 associated lipids |
| Stomatitis | D013280 | 14 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Gurban CV and Mederle O | The OPG/RANKL system and zinc ions are promoters of bone remodeling by osteoblast proliferation in postmenopausal osteoporosis. | 2011 | Rom J Morphol Embryol | pmid:22119834 |
| Gordon IK and Camphausen K | Research highlights. | 2011 | Biomark Med | pmid:21861664 |
| Sood SK et al. | Osteoprotegerin (OPG) and related proteins (RANK, RANKL and TRAIL) in thyroid disease. | 2011 | World J Surg | pmid:21748518 |
| Stein SH and Tipton DA | Vitamin D and its impact on oral health--an update. | 2011 | J Tenn Dent Assoc | pmid:21748977 |
| Xie H et al. | Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression. | 2011 | Cardiovasc. Res. | pmid:21750093 |
| Wang Y et al. | Alendronate (ALN) combined with osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats. | 2011 | J Orthop Surg Res | pmid:21752290 |
| Jabbar S et al. | Plasma vitamin D and cytokines in periodontal disease and postmenopausal osteoporosis. | 2011 | J. Periodont. Res. | pmid:20731767 |
| Curl L and Sampson W | The presence of TNF-alpha and TNFR1 in aseptic root resorption. A preliminary study. | 2011 | Aust Orthod J | pmid:22372265 |
| Lossdörfer S et al. | PTH(1-34)-induced changes in RANKL and OPG expression by human PDL cells modify osteoclast biology in a co-culture model with RAW 264.7 cells. | 2011 | Clin Oral Investig | pmid:20697756 |
| Tipton DA et al. | Effect of bisphosphonates on human gingival fibroblast production of mediators of osteoclastogenesis: RANKL, osteoprotegerin and interleukin-6. | 2011 | J. Periodont. Res. | pmid:20701670 |
| Harada S and Takahashi N | [Control of bone resorption by RANKL-RANK system]. | 2011 | Clin Calcium | pmid:21814016 |
| Nakamura M and Udagawa N | [Osteoporosis and RANKL signal]. | 2011 | Clin Calcium | pmid:21814019 |
| Persson E and Lerner UH | The neuropeptide VIP regulates the expression of osteoclastogenic factors in osteoblasts. | 2011 | J. Cell. Biochem. | pmid:21815197 |
| Üstündağ M et al. | The role of serum osteoprotegerin and S-100 protein levels in patients with acute ischaemic stroke: determination of stroke subtype, severity and mortality. | 2011 | J. Int. Med. Res. | pmid:21819709 |
| Bellido M et al. | Improving subchondral bone integrity reduces progression of cartilage damage in experimental osteoarthritis preceded by osteoporosis. | 2011 | Osteoarthr. Cartil. | pmid:21820069 |
| Lawrie A et al. | Paigen diet-fed apolipoprotein E knockout mice develop severe pulmonary hypertension in an interleukin-1-dependent manner. | 2011 | Am. J. Pathol. | pmid:21835155 |
| Poulsen MK et al. | Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus. | 2011 | Cardiovasc Diabetol | pmid:21838881 |
| Sudrová M et al. | Influence of long-term thromboprophylaxis with low-molecular-weight heparin (enoxaparin) on changes of bone metabolism markers in pregnant women. | 2011 | Clin. Appl. Thromb. Hemost. | pmid:20682598 |
| Mamalis AA et al. | Chemical modification of an implant surface increases osteogenesis and simultaneously reduces osteoclastogenesis: an in vitro study. | 2011 | Clin Oral Implants Res | pmid:21070383 |
| Vitoratos N et al. | Maternal circulating osteoprotegerin and soluble RANKL in pre-eclamptic women. | 2011 | Eur. J. Obstet. Gynecol. Reprod. Biol. | pmid:21074311 |
| Belibasakis GN et al. | Oral biofilm challenge regulates the RANKL-OPG system in periodontal ligament and dental pulp cells. | 2011 | Microb. Pathog. | pmid:21075196 |
| Nybo M et al. | Rosiglitazone decreases plasma levels of osteoprotegerin in a randomized clinical trial with type 2 diabetes patients. | 2011 | Basic Clin. Pharmacol. Toxicol. | pmid:21726411 |
| Fradet A et al. | Dual function of ERRα in breast cancer and bone metastasis formation: implication of VEGF and osteoprotegerin. | 2011 | Cancer Res. | pmid:21734015 |
| Kaneko K and Kawai S | [Mechanisms and therapeutics of glucocorticoid-induced osteoporosis]. | 2011 | Nihon Rinsho Meneki Gakkai Kaishi | pmid:21720102 |
| Taylor R et al. | Osteoclast formation and function in pigmented villonodular synovitis. | 2011 | J. Pathol. | pmid:21706481 |
| Zhang Y et al. | Study of the mechanisms by which Sambucus williamsii HANCE extract exert protective effects against ovariectomy-induced osteoporosis in vivo. | 2011 | Osteoporos Int | pmid:20414641 |
| Conaway HH et al. | Retinoids stimulate periosteal bone resorption by enhancing the protein RANKL, a response inhibited by monomeric glucocorticoid receptor. | 2011 | J. Biol. Chem. | pmid:21715325 |
| Hie M and Tsukamoto I | Vitamin C-deficiency stimulates osteoclastogenesis with an increase in RANK expression. | 2011 | J. Nutr. Biochem. | pmid:20444587 |
| El-Shehaby A et al. | Correlations of urinary biomarkers, TNF-like weak inducer of apoptosis (TWEAK), osteoprotegerin (OPG), monocyte chemoattractant protein-1 (MCP-1), and IL-8 with lupus nephritis. | 2011 | J. Clin. Immunol. | pmid:21691937 |
| Nich C et al. | Oestrogen deficiency modulates particle-induced osteolysis. | 2011 | Arthritis Res. Ther. | pmid:21696618 |
| Clézardin P | [The role of RANK/RANKL/osteoprotegerin (OPG) triad in cancer-induced bone diseases: physiopathology and clinical implications]. | 2011 | Bull Cancer | pmid:21700551 |
| Celczyńska Bajew L et al. | The effects of osteoprotegerin (OPG) gene polymorphism in patients with ischaemic heart disease on the morphology of coronary arteries and bone mineral density. | 2011 | Kardiol Pol | pmid:21678294 |
| Dzida G | [Decalcified bones, calcified heart?]. | 2011 | Kardiol Pol | pmid:21678295 |
| Yang Q et al. | Plasma osteoprotegerin levels and long-term prognosis in patients with intermediate coronary artery lesions. | 2011 | Clin Cardiol | pmid:21678453 |
| Cianciolo G et al. | Effects of unfractioned heparin and low-molecular-weight heparin on osteoprotegerin and RANKL plasma levels in haemodialysis patients. | 2011 | Nephrol. Dial. Transplant. | pmid:20659908 |
| Chasseraud M et al. | Tumor necrosis factor-related apoptosis-inducing ligand and vascular calcification. | 2011 | Ther Apher Dial | pmid:21426505 |
| Duheron V et al. | Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit. | 2011 | Proc. Natl. Acad. Sci. U.S.A. | pmid:21402940 |
| Vishvanath A et al. | Infantile haemangioma expresses tumour necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptors, osteoprotegerin and receptor activator for nuclear factor кB ligand (RANKL). | 2011 | Histopathology | pmid:22034880 |
| Dimitrow PP et al. | The influence of statins on levels of calcification biomarkers in patients with aortic sclerosis or mild aortic stenosis. | 2011 | J. Heart Valve Dis. | pmid:21404893 |
| Vidal C et al. | Functional polymorphisms within the TNFRSF11B (osteoprotegerin) gene increase the risk for low bone mineral density. | 2011 | J. Mol. Endocrinol. | pmid:21994215 |
| Marques EA et al. | Effects of resistance and aerobic exercise on physical function, bone mineral density, OPG and RANKL in older women. | 2011 | Exp. Gerontol. | pmid:21316442 |
| Chin A et al. | Effects of medicinal herb salvia miltiorrhiza on osteoblastic cells in vitro. | 2011 | J. Orthop. Res. | pmid:21319217 |
| Hemingway F et al. | In vitro generation of mature human osteoclasts. | 2011 | Calcif. Tissue Int. | pmid:21960377 |
| Mencej-BedraÄ S et al. | TNFRSF11B gene polymorphisms 1181G > C and 245T > G as well as haplotype CT influence bone mineral density in postmenopausal women. | 2011 | Maturitas | pmid:21411255 |
| Dimitriadis K et al. | Exercise blood pressure response is related to asymmetric dimethylarginine and osteoprotegerin in hypertension. | 2011 | Int. J. Cardiol. | pmid:21975354 |
| Lee JC et al. | Role of RANK-RANKL-OPG axis in cranial suture homeostasis. | 2011 | J Craniofac Surg | pmid:21415639 |
| Yao Y et al. | Synergistic enhancement of new bone formation by recombinant human bone morphogenetic protein-2 and osteoprotegerin in trans-sutural distraction osteogenesis: a pilot study in dogs. | 2011 | J. Oral Maxillofac. Surg. | pmid:22018252 |
| Mercatali L et al. | Bone metastases detection by circulating biomarkers: OPG and RANK-L. | 2011 | Int. J. Oncol. | pmid:21491082 |
| Stein SH et al. | Statins regulate interleukin-1β-induced RANKL and osteoprotegerin production by human gingival fibroblasts. | 2011 | J. Periodont. Res. | pmid:21463327 |
| Liang QQ et al. | The expression of osteoprotegerin is required for maintaining the intervertebral disc endplate of aged mice. | 2011 | Bone | pmid:21466864 |
| Honda K | Interleukin-6 and soluble interleukin-6 receptor suppress osteoclastic differentiation by inducing PGE(2) production in chondrocytes. | 2011 | J Oral Sci | pmid:21467819 |
| Moldenhauer A et al. | Interleukin 32 promotes hematopoietic progenitor expansion and attenuates bone marrow cytotoxicity. | 2011 | Eur. J. Immunol. | pmid:21469100 |
| Kim H et al. | Association between Wnt signaling pathway gene polymorphisms and bone response to hormone therapy in postmenopausal Korean women. | 2011 | Menopause | pmid:21471826 |
| Mulcahy LE et al. | RANKL and OPG activity is regulated by injury size in networks of osteocyte-like cells. | 2011 | Bone | pmid:20854946 |
| Aspenberg P et al. | Targeting RANKL for reduction of bone loss around unstable implants: OPG-Fc compared to alendronate in a model for mechanically induced loosening. | 2011 | Bone | pmid:20858557 |
| Kurnatowska I et al. | Serum osteoprotegerin is a predictor of progression of atherosclerosis and coronary calcification in hemodialysis patients. | 2011 | Nephron Clin Pract | pmid:20861651 |
| Kassi E et al. | Effects of Sideritis euboea (Lamiaceae) aqueous extract on IL-6, OPG and RANKL secretion by osteoblasts. | 2011 | Nat Prod Commun | pmid:22224290 |
| Dimitri P et al. | Adipokines, bone-derived factors and bone turnover in obese children; evidence for altered fat-bone signalling resulting in reduced bone mass. | 2011 | Bone | pmid:20932948 |
| Yu H et al. | Overexpression of osteoprotegerin promotes preosteoblast differentiation to mature osteoblasts. | 2011 | Angle Orthod | pmid:20936961 |
| Palaniswamy C et al. | Association of warfarin use with valvular and vascular calcification: a review. | 2011 | Clin Cardiol | pmid:21298649 |
| Bostanci N et al. | Effect of periodontal treatment on receptor activator of NF-κB ligand and osteoprotegerin levels and relative ratio in gingival crevicular fluid. | 2011 | J. Clin. Periodontol. | pmid:21261673 |
| Andersen GØ et al. | Elevated serum osteoprotegerin levels measured early after acute ST-elevation myocardial infarction predict final infarct size. | 2011 | Heart | pmid:21270073 |
| Tsukamoto S et al. | Clinical significance of osteoprotegerin expression in human colorectal cancer. | 2011 | Clin. Cancer Res. | pmid:21270110 |
| Monnouchi S et al. | The roles of angiotensin II in stretched periodontal ligament cells. | 2011 | J. Dent. Res. | pmid:21270461 |
| Choe JY et al. | Radiographic bone damage in chronic gout is negatively associated with the inflammatory cytokines soluble interleukin 6 receptor and osteoprotegerin. | 2011 | J. Rheumatol. | pmid:21159831 |
| Mahoney DJ et al. | TSG-6 inhibits osteoclast activity via an autocrine mechanism and is functionally synergistic with osteoprotegerin. | 2011 | Arthritis Rheum. | pmid:21162099 |
| Nahidi L et al. | Osteoprotegerin in pediatric Crohn's disease and the effects of exclusive enteral nutrition. | 2011 | Inflamm. Bowel Dis. | pmid:20848544 |
| Čolović M et al. | FGF-R3 and OPG expression in patient with multiple myeloma following systemic sclerosis: case report and review of the literature. | 2011 | Int. J. Hematol. | pmid:21207214 |
| Hashiguchi D et al. | Mineral trioxide aggregate solution inhibits osteoclast differentiation through the maintenance of osteoprotegerin expression in osteoblasts. | 2011 | J Biomed Mater Res A | pmid:21171155 |
| Li JY et al. | Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand. | 2011 | Proc. Natl. Acad. Sci. U.S.A. | pmid:21187391 |
| Feng Z et al. | An oligodeoxynucleotide with promising modulation activity for the proliferation and activation of osteoblast. | 2011 | Int J Mol Sci | pmid:21731457 |
| Tang Y et al. | Porphyromonas endodontalis lipopolysaccharides induce RANKL by mouse osteoblast in a way different from that of Escherichia coli lipopolysaccharide. | 2011 | J Endod | pmid:22099899 |
| Kuczkowski J et al. | Expression of the receptor activator for nuclear factor-κB ligand and osteoprotegerin in chronic otitis media. | 2010 Nov-Dec | Am J Otolaryngol | pmid:20015790 |
| Kuczkowski J et al. | [Molecular control of bone resorption in chronic otitis media with cholesteatoma]. | 2010 Jul-Aug | Otolaryngol Pol | pmid:20873097 |
| Reyes-GarcÃa R et al. | Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor kappaB in women with postmenopausal osteoporosis. | 2010 Jan-Feb | Menopause | pmid:19574937 |
| Mori K et al. | Effects of pravastatin on serum osteoprotegerin levels in patients with hypercholesterolemia and type 2 diabetes. | 2010 Feb-Mar | Angiology | pmid:19147525 |
| Akat K et al. | Calcium metabolism in adults with severe aortic valve stenosis and preserved renal function. | 2010 | Am. J. Cardiol. | pmid:20211333 |
| Canon J et al. | Inhibition of RANKL increases the anti-tumor effect of the EGFR inhibitor panitumumab in a murine model of bone metastasis. | 2010 | Bone | pmid:20215062 |
| Winzer M et al. | Glycitein decreases the generation of murine osteoclasts and increases apoptosis. | 2010 | Wien Med Wochenschr | pmid:20714813 |
| Gruber R | Cell biology of osteoimmunology. | 2010 | Wien Med Wochenschr | pmid:20714814 |
| Jang S et al. | Wogonin inhibits osteoclast formation induced by lipopolysaccharide. | 2010 | Phytother Res | pmid:19998398 |
| Sanuki R et al. | Compressive force induces osteoclast differentiation via prostaglandin E(2) production in MC3T3-E1 cells. | 2010 | Connect. Tissue Res. | pmid:20001844 |
| Ikeda K et al. | [Animal models for vascular calcification]. | 2010 | Clin Calcium | pmid:21037386 |
| Hamed EA et al. | Iron chelation therapy in Upper Egyptian transfusion-dependent pediatric homozygous beta-thalassemia major: impact on serum L-carnitine/free fatty acids, osteoprotegerin/the soluble receptor activator of nuclear factor-kappabeta ligand systems, and bone mineral density. | 2010 | J. Pediatr. Hematol. Oncol. | pmid:20445416 |
| Tenta R et al. | Osteoprotegerin and nuclear factor-kappaB ligand are associated with leptin and adiponectin levels, in apparently healthy women. | 2010 | J Musculoskelet Neuronal Interact | pmid:20516635 |
| Scott JP et al. | The effect of training status on the metabolic response of bone to an acute bout of exhaustive treadmill running. | 2010 | J. Clin. Endocrinol. Metab. | pmid:20519353 |
| Bu YH et al. | Insulin receptor substrate 1 regulates the cellular differentiation and the matrix metallopeptidase expression of preosteoblastic cells. | 2010 | J. Endocrinol. | pmid:20525764 |
| Duan XH et al. | [The endocrine function of the skeleton]. | 2010 | Sheng Li Ke Xue Jin Zhan | pmid:21416939 |
| Komosińska-Vassev K et al. | [Osteoporosis--pathophysiology and laboratory diagnostic methods]. | 2010 | Prz. Lek. | pmid:21387765 |
| Xu Y et al. | Inhibition of bone metastasis from breast carcinoma by rosmarinic acid. | 2010 | Planta Med. | pmid:20157877 |
| Ooi LL et al. | Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis. | 2010 | Cancer Res. | pmid:20160035 |
| Dimitrow PP | Aortic valve stenosis as a complex inflammatory-hematological-osteogenic disease. | 2010 | Atherosclerosis | pmid:20864109 |
| Dereka XE et al. | RANKL and OPG mRNA level after non-surgical periodontal treatment. | 2010 | Inflammation | pmid:20033478 |
| Kolahi S et al. | Fish oil supplementation decreases serum soluble receptor activator of nuclear factor-kappa B ligand/osteoprotegerin ratio in female patients with rheumatoid arthritis. | 2010 | Clin. Biochem. | pmid:20034487 |
| Petri AD et al. | Effects of low-level laser therapy on human osteoblastic cells grown on titanium. | 2010 | Braz Dent J | pmid:21271038 |
| Breland UM et al. | Inflammatory markers in patients with coronary artery disease with and without inflammatory rheumatic disease. | 2010 | Rheumatology (Oxford) | pmid:20231178 |
| Assmann G et al. | Genetic variations in genes encoding RANK, RANKL, and OPG in rheumatoid arthritis: a case-control study. | 2010 | J. Rheumatol. | pmid:20231205 |
| Pino AM et al. | Concentration of adipogenic and proinflammatory cytokines in the bone marrow supernatant fluid of osteoporotic women. | 2010 | J. Bone Miner. Res. | pmid:19653807 |
| O'Sullivan EP et al. | Osteoprotegerin and biomarkers of vascular inflammation in type 2 diabetes. | 2010 | Diabetes Metab. Res. Rev. | pmid:20809534 |
| Klika V and Marsik F | A thermodynamic model of bone remodelling: the influence of dynamic loading together with biochemical control. | 2010 | J Musculoskelet Neuronal Interact | pmid:20811146 |